Anna Greka's most recent trade in Ovid Therapeutics Inc was a trade of 130,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Anna Greka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 130,000 | 130,000 | - | - | Stock Option (right to buy) |